Real-time enrollment status for this graft versus host disease clinical trial
Current Status
Active, Not Recruiting
Checked: June 1, 2026 at 11:34 PM UTC
| NCT Number | NCT05643638 |
| Recruiting Status | Active, Not Recruiting |
| Condition | Graft versus Host Disease |
| Phase | Clinical Trial |
| Target Enrollment | 60 participants |
| Active Locations | 13 sites in the US |
| Sponsor | Cynata Therapeutics Limited |
| Last Updated on CT.gov | May 26, 2026 (6 days ago) |
As of June 1, 2026: Clinical trial NCT05643638 is currently active_not_recruiting participants. This clinical trial study for graft versus host disease is not currently accepting new participants at 13 locations across the United States. The study is sponsored by Cynata Therapeutics Limited. This status information is automatically verified from the official ClinicalTrials.gov registry.
No, NCT05643638 is currently active_not_recruiting. The study may resume recruiting in the future.
This trial is recruiting at 13 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05643638 was last updated 6 days ago (May 26, 2026). HelloStudys verifies this status automatically.